Friday, April 20, 2018
By PR Newswire
PITTSBURGH, April 17, 2018 /PRNewswire/ -- Highmark Inc. has entered into an outcomes-based contract with AstraZeneca for the well-known medicine Symbicort®. Indicated for the treatment of asthma and chronic obstructive pulmonary disease (COPD), Symbicort helps decrease inflammation and open up the airways.....   [READ MORE]

BEIJING, April 19, 2018 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac " or the "Company"), a leading provider of biopharmaceutical products in China, today announced preliminary results of a phase III clinical study on Sabin inactivated polio vaccine ("sIPV") developed by Sinova.....   [READ MORE]
LOS ANGELES, April 19, 2018 /PRNewswire/ -- The American Brain Foundation will recognize three people for their leadership of movements to defeat brain diseases afflicting 50 million Americans at an event held in conjunction with the Annual Meeting of the American Academy of Neurology on   [READ MORE]

- Expresses Concern over Aggressive and Damaging Actions Taken by a Minority Shareholder of Sinovac's Beijing Subsidiary –   [READ MORE]

STOCKHOLM, April 18, 2018 /PRNewswire/ -- The latest version of a hand-held device to help people improve the self-management of ongoing lung conditions is being launched this month.   [READ MORE]
10 April, 2018 - During the press meet held today at their head office, the spokesperson for Center for Health and Wellness said that they are dedicate...   [READ MORE]

About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines